All the news and blogs
Business & Finance
Tech & Science
Our mobile app
Our groups in social networks
Nothing was found on your request
Attorneys general in 21 states reject opioid companies settlement because $18 billion is not enough
States across the country have sued major opioid distributors and pharmaceutical companies for compensation due to the unscrupulous practices that have helped to facilitate the opioid crisis. The Wall
Purdue Pharma bankruptcy is now open to OxyContin-related personal injury claims
The federal judge handling the bankruptcy case of Purdue Pharma set a June 30 deadline to file a personal injury claim against the company for its opioids.
New York Attorney General Clears Path for Production of Opioid Overdose Antidote
“[M]y office will do whatever possible to ensure that there are no unnecessary impediments to the development of additional life-saving opioid overdose reversal drugs,” said Attorney General Letitia
Obscure state regulations gave birth to the opioid crisis
Economists found a difference in state regulations was all Purdue Pharma needed.
Report: Sacklers using fake doctors, false marketing to sell OxyContin in China
As Purdue files for bankruptcy, business in China is ramping up.
OxyContin’s Maker Is Still Flourishing In China
This is the web version of Brainstorm Health Daily, Fortune’s daily newsletter on the top health care news. To get it delivered daily to your in-box, sign up here. Good afternoon, readers. The opioid
Billionaire Sackler family accused of pushing addictive opioids in China
The Sackler family are owners of the drug company that caused a devastating drug crisis in the United States by making false claims about the safety of its highly addictive OxyContin. According to an
Sacklers get extra bankruptcy protections as legal experts call for probe
Legal scholars say a special examiner could bring transparency to the Sacklers.
Four major players in the US opioid crisis reached a tentative deal in Ohio
Lawyers for the plaintiffs said the settlement would provide much-needed funds for addiction recovery programs.
The Massive Opioid Trial Set to Start Today Just Took a Big Turn
Now there's only one defendant remaining in a test case meant to be the guide for future opioid litigation across the U.S.
Oligarch of the Month: The Sacklers
Not so long ago, the Sackler name was stamped across the most rarified perches in Manhattan—in the psychobiology department at Columbia University, at the Metropolitan Museum of Art, and at the Museum
VA doctor sentenced to 40 years for writing over 500,000 opioid prescriptions in less than 2 years
On Wednesday, Virginia doctor Joel Smithers was sentenced to 40 years for his part in the opioid crisis. Smithers was found guilty by a jury in May of more than 800 federal drug charges. Prosecutors
24 State AGs Want to Stop Purdue Pharma From Paying Millions in Bonuses During Bankruptcy
“Multi-billionaires who are giving millions in bonuses to their employees are the opposite of bankrupt,” said North Carolina's attorney general.
Prestigious Universities Received $60 Million in Donations from OxyContin Family
The Sackler family, who own Purdue Pharma, the developer of opioid OxyContin, donated $60 million to various prestigious universities around the world including Yale, according to a report published
OxyContin-pushing Sackler billionaires demand ‘the benefit of bankruptcy without the burdens’
The extremely private family that made billions from the sale of OxyContin is threatening to back out of bankruptcy negotiations that could potentially expose the depth of its corruption.The Sacklers
Sacklers threaten to scrap opioid deal if they aren’t shielded from lawsuits
Sacklers seek "the benefit of bankruptcy without the burdens of bankruptcy."
We Didn’t Stand a Chance Against Opioids
My ancestors had no written language, so they told their stories to the trees. Ten thousand years after the Tlingit people settled Alaska’s southeastern archipelago, these islands remain stippled with
After Sacklers shift at least $1 billion around, Purdue files for bankruptcy
The OxyContin-maker filed for bankruptcy as part of a proposed $10-$12 billion deal.
Why Purdue Pharma's Bankruptcy Won't Save the Sacklers, the Billionaire Family Behind OxyContin
Several states have already sued — or vowed to sue — the family directly.
The Case for a Public Option for the Drug Industry
Under siege from thousands of lawsuits from federal, state, and local governments for its role in the deadly opioid addiction crisis, drug manufacturer Purdue Pharma reached a tentative settlement